Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

SHILPA MEDICARE LTD.

NSE : SHILPAMEDBSE : 530549ISIN CODE : INE790G01031Industry : Pharmaceuticals & DrugsHouse : Private

BSE326.202.9 (+0.9 %)

PREV CLOSE ( ) 323.30

OPEN PRICE ( ) 321.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 15722

TODAY'S LOW / HIGH ( )315.60 335.55

52 WK LOW / HIGH ( )260 501.6

NSE326.803.65 (+1.13 %)

PREV CLOSE( ) 323.15

OPEN PRICE ( ) 320.80

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 463824

TODAY'S LOW / HIGH( ) 316.00 336.25

52 WK LOW / HIGH ( )259.5 500

Select year

(Rs.in Million)

Particulars

Mar 2025

Mar 2024

Mar 2023

Mar 2022

Mar 2021

Profit Before Tax

1223.33

543.41

-382.80

1022.65

1950.52

Adjustment

1950.44

2214.37

1478.07

1093.42

57.62

Changes In working Capital

-1381.75

-979.20

1027.71

-719.91

-1062.86

Cash Flow after changes in Working Capital

1792.01

1778.58

2122.98

1396.16

945.28

Cash Flow from Operating Activities

1321.79

1366.69

1799.24

1051.33

469.28

Cash Flow from Investing Activities

-1990.85

-1665.84

-2326.12

-2854.98

-4042.76

Cash Flow from Financing Activities

626.54

467.75

457.98

828.58

4363.74

Net Cash Inflow / Outflow

-42.52

168.60

-68.91

-975.07

790.26

Opening Cash & Cash Equivalents

317.56

190.71

256.22

1228.46

443.14

Cash & Cash Equivalent on Amalgamation / Take over / Merger

Cash & Cash Equivalent of Subsidiaries under liquidations

Translation adjustment on reserves / op cash balalces frgn subsidiaries

Effect of Foreign Exchange Fluctuations

10.20

-41.75

3.40

Closing Cash & Cash Equivalent

285.24

317.56

190.71

253.39

1233.40